Orthofix Medical Inc. (OFIX)
USD 14.56
(-6.34%)
USD 14.56
(-6.34%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 746.64 Million USD | 62.06% |
| 2022 | 460.71 Million USD | -0.81% |
| 2021 | 464.47 Million USD | 14.25% |
| 2020 | 406.56 Million USD | -11.61% |
| 2019 | 459.95 Million USD | 1.53% |
| 2018 | 453.04 Million USD | 4.43% |
| 2017 | 433.82 Million USD | 5.87% |
| 2016 | 409.78 Million USD | 3.35% |
| 2015 | 396.48 Million USD | -1.44% |
| 2014 | 402.27 Million USD | 0.44% |
| 2013 | 400.53 Million USD | -13.36% |
| 2012 | 462.32 Million USD | -20.15% |
| 2011 | 578.98 Million USD | 2.59% |
| 2010 | 564.37 Million USD | 3.43% |
| 2009 | 545.63 Million USD | 5.0% |
| 2008 | 519.67 Million USD | 5.99% |
| 2007 | 490.32 Million USD | 34.2% |
| 2006 | 365.35 Million USD | 16.61% |
| 2005 | 313.3 Million USD | 9.3% |
| 2004 | 286.63 Million USD | 40.71% |
| 2003 | 203.7 Million USD | 14.7% |
| 2002 | 177.59 Million USD | 9.38% |
| 2001 | 162.36 Million USD | 23.2% |
| 2000 | 131.78 Million USD | 8.66% |
| 1999 | 121.28 Million USD | 16.51% |
| 1998 | 104.1 Million USD | 15.67% |
| 1997 | 90 Million USD | 16.58% |
| 1996 | 77.2 Million USD | 47.61% |
| 1995 | 52.3 Million USD | 32.07% |
| 1994 | 39.6 Million USD | 26.11% |
| 1993 | 31.4 Million USD | 12.14% |
| 1992 | 28 Million USD | 33.97% |
| 1991 | 20.9 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 198.62 Million USD | 5.31% |
| 2024 Q1 | 188.6 Million USD | -5.89% |
| 2023 Q1 | 175.2 Million USD | 43.34% |
| 2023 FY | 746.64 Million USD | 62.06% |
| 2023 Q2 | 187.01 Million USD | 6.74% |
| 2023 Q3 | 184 Million USD | -1.61% |
| 2023 Q4 | 200.41 Million USD | 8.92% |
| 2022 Q1 | 106.41 Million USD | -14.91% |
| 2022 Q3 | 113.99 Million USD | -3.45% |
| 2022 FY | 460.71 Million USD | -0.81% |
| 2022 Q2 | 118.07 Million USD | 10.95% |
| 2022 Q4 | 122.22 Million USD | 7.22% |
| 2021 FY | 464.47 Million USD | 14.25% |
| 2021 Q1 | 105.59 Million USD | -10.22% |
| 2021 Q2 | 121.39 Million USD | 14.96% |
| 2021 Q3 | 112.42 Million USD | -7.39% |
| 2021 Q4 | 125.06 Million USD | 11.24% |
| 2020 Q3 | 110.98 Million USD | 51.75% |
| 2020 Q1 | 104.82 Million USD | -13.72% |
| 2020 Q4 | 117.61 Million USD | 5.98% |
| 2020 FY | 406.56 Million USD | -11.61% |
| 2020 Q2 | 73.13 Million USD | -30.23% |
| 2019 Q1 | 109.11 Million USD | -9.88% |
| 2019 Q2 | 115.85 Million USD | 6.18% |
| 2019 Q3 | 113.49 Million USD | -2.03% |
| 2019 Q4 | 121.49 Million USD | 7.04% |
| 2019 FY | 459.95 Million USD | 1.53% |
| 2018 Q4 | 121.07 Million USD | 8.39% |
| 2018 FY | 453.04 Million USD | 4.43% |
| 2018 Q2 | 111.54 Million USD | 2.61% |
| 2018 Q3 | 111.7 Million USD | 0.14% |
| 2018 Q1 | 108.7 Million USD | -7.0% |
| 2017 Q1 | 102.73 Million USD | -5.34% |
| 2017 Q4 | 116.89 Million USD | 11.07% |
| 2017 Q3 | 105.24 Million USD | -3.39% |
| 2017 FY | 433.82 Million USD | 5.87% |
| 2017 Q2 | 108.94 Million USD | 6.04% |
| 2016 FY | 409.78 Million USD | 3.35% |
| 2016 Q4 | 108.53 Million USD | 10.19% |
| 2016 Q1 | 98.67 Million USD | -5.68% |
| 2016 Q3 | 98.49 Million USD | -5.36% |
| 2016 Q2 | 104.07 Million USD | 5.47% |
| 2015 Q3 | 101.15 Million USD | 0.2% |
| 2015 Q1 | 89.76 Million USD | -10.49% |
| 2015 FY | 396.48 Million USD | -1.44% |
| 2015 Q2 | 100.95 Million USD | 12.47% |
| 2015 Q4 | 104.62 Million USD | 3.43% |
| 2014 Q1 | 101.34 Million USD | -4.52% |
| 2014 Q4 | 100.28 Million USD | -0.7% |
| 2014 Q2 | 100.98 Million USD | -0.35% |
| 2014 FY | 402.27 Million USD | 0.44% |
| 2014 Q3 | 100.99 Million USD | 0.01% |
| 2013 Q3 | 92.73 Million USD | -5.64% |
| 2013 FY | 400.53 Million USD | -13.36% |
| 2013 Q4 | 106.14 Million USD | 14.45% |
| 2013 Q2 | 98.28 Million USD | -1.97% |
| 2013 Q1 | 100.25 Million USD | -10.52% |
| 2012 Q4 | 112.03 Million USD | -2.37% |
| 2012 FY | 462.32 Million USD | -20.15% |
| 2012 Q1 | 143.14 Million USD | -5.53% |
| 2012 Q2 | 119.49 Million USD | -16.52% |
| 2012 Q3 | 114.75 Million USD | -3.97% |
| 2011 FY | 578.98 Million USD | 2.59% |
| 2011 Q4 | 151.52 Million USD | 4.68% |
| 2011 Q2 | 143.55 Million USD | 3.15% |
| 2011 Q3 | 144.74 Million USD | 0.83% |
| 2011 Q1 | 139.16 Million USD | -3.22% |
| 2010 FY | 564.37 Million USD | 3.43% |
| 2010 Q4 | 143.79 Million USD | 3.52% |
| 2010 Q1 | 138.82 Million USD | -3.61% |
| 2010 Q2 | 142.84 Million USD | 2.9% |
| 2010 Q3 | 138.9 Million USD | -2.76% |
| 2009 Q4 | 144.01 Million USD | 6.6% |
| 2009 Q3 | 135.09 Million USD | -1.78% |
| 2009 Q1 | 128.97 Million USD | -2.52% |
| 2009 Q2 | 137.54 Million USD | 6.65% |
| 2009 FY | 545.63 Million USD | 5.0% |
| 2008 Q4 | 132.3 Million USD | 2.32% |
| 2008 Q1 | 128.03 Million USD | -0.62% |
| 2008 Q2 | 130.03 Million USD | 1.57% |
| 2008 FY | 519.67 Million USD | 5.99% |
| 2008 Q3 | 129.3 Million USD | -0.57% |
| 2007 FY | 490.32 Million USD | 34.2% |
| 2007 Q4 | 128.83 Million USD | 6.37% |
| 2007 Q1 | 117.03 Million USD | 0.77% |
| 2007 Q3 | 121.12 Million USD | -1.8% |
| 2007 Q2 | 123.33 Million USD | 5.39% |
| 2006 Q2 | 84.73 Million USD | 4.46% |
| 2006 FY | 365.35 Million USD | 16.61% |
| 2006 Q4 | 116.14 Million USD | 39.31% |
| 2006 Q1 | 81.11 Million USD | 1.06% |
| 2006 Q3 | 83.36 Million USD | -1.61% |
| 2005 Q2 | 79.54 Million USD | 2.38% |
| 2005 FY | 313.3 Million USD | 9.3% |
| 2005 Q4 | 80.26 Million USD | 5.87% |
| 2005 Q3 | 75.81 Million USD | -4.69% |
| 2005 Q1 | 77.68 Million USD | 5.53% |
| 2004 Q1 | 70.73 Million USD | 34.21% |
| 2004 Q3 | 71.48 Million USD | 0.98% |
| 2004 Q2 | 70.79 Million USD | 0.08% |
| 2004 Q4 | 73.61 Million USD | 2.98% |
| 2004 FY | 286.63 Million USD | 40.71% |
| 2003 Q3 | 51.25 Million USD | -0.61% |
| 2003 FY | 203.7 Million USD | 14.7% |
| 2003 Q1 | 48.18 Million USD | 5.02% |
| 2003 Q2 | 51.56 Million USD | 7.02% |
| 2003 Q4 | 52.7 Million USD | 2.84% |
| 2002 Q3 | 44.54 Million USD | -2.28% |
| 2002 Q1 | 41.59 Million USD | -3.27% |
| 2002 Q2 | 45.58 Million USD | 9.58% |
| 2002 FY | 177.59 Million USD | 9.38% |
| 2002 Q4 | 45.87 Million USD | 3.0% |
| 2001 Q4 | 42.99 Million USD | 7.07% |
| 2001 Q3 | 40.15 Million USD | -1.41% |
| 2001 Q1 | 38.47 Million USD | 14.64% |
| 2001 Q2 | 40.73 Million USD | 5.88% |
| 2001 FY | 162.36 Million USD | 23.2% |
| 2000 Q1 | 33.27 Million USD | 6.37% |
| 2000 Q4 | 33.55 Million USD | 5.2% |
| 2000 Q3 | 31.89 Million USD | -3.49% |
| 2000 FY | 131.78 Million USD | 8.66% |
| 2000 Q2 | 33.05 Million USD | -0.67% |
| 1999 FY | 121.28 Million USD | 16.51% |
| 1999 Q2 | 30.6 Million USD | 2.34% |
| 1999 Q4 | 31.28 Million USD | 6.05% |
| 1999 Q3 | 29.5 Million USD | -3.59% |
| 1999 Q1 | 29.9 Million USD | 9.93% |
| 1998 Q3 | 26.4 Million USD | 3.53% |
| 1998 FY | 104.1 Million USD | 15.67% |
| 1998 Q4 | 27.2 Million USD | 3.03% |
| 1998 Q1 | 25 Million USD | 3.31% |
| 1998 Q2 | 25.5 Million USD | 2.0% |
| 1997 Q2 | 22.4 Million USD | 8.74% |
| 1997 FY | 90 Million USD | 16.58% |
| 1997 Q4 | 24.2 Million USD | 6.14% |
| 1997 Q3 | 22.8 Million USD | 1.79% |
| 1997 Q1 | 20.6 Million USD | 3.0% |
| 1996 Q3 | 19.2 Million USD | 1.05% |
| 1996 Q4 | 20 Million USD | 4.17% |
| 1996 Q2 | 19 Million USD | 0.0% |
| 1996 FY | 77.2 Million USD | 47.61% |
| 1996 Q1 | 19 Million USD | 13.1% |
| 1995 FY | 52.3 Million USD | 32.07% |
| 1995 Q4 | 16.8 Million USD | 35.48% |
| 1995 Q1 | 11.5 Million USD | 4.55% |
| 1995 Q2 | 11.6 Million USD | 0.87% |
| 1995 Q3 | 12.4 Million USD | 6.9% |
| 1994 Q4 | 11 Million USD | 13.4% |
| 1994 Q2 | 9.6 Million USD | 3.23% |
| 1994 Q1 | 9.3 Million USD | 8.14% |
| 1994 FY | 39.6 Million USD | 26.11% |
| 1994 Q3 | 9.7 Million USD | 1.04% |
| 1993 Q4 | 8.6 Million USD | 19.44% |
| 1993 FY | 31.4 Million USD | 12.14% |
| 1993 Q3 | 7.2 Million USD | -6.49% |
| 1993 Q2 | 7.7 Million USD | -1.28% |
| 1993 Q1 | 7.8 Million USD | 6.85% |
| 1992 Q1 | 7.1 Million USD | 33.96% |
| 1992 FY | 28 Million USD | 33.97% |
| 1992 Q4 | 7.3 Million USD | 5.8% |
| 1992 Q3 | 6.9 Million USD | 4.55% |
| 1992 Q2 | 6.6 Million USD | -7.04% |
| 1991 Q3 | 5.2 Million USD | 0.0% |
| 1991 FY | 20.9 Million USD | 0.0% |
| 1991 Q1 | 5.2 Million USD | 0.0% |
| 1991 Q2 | 5.2 Million USD | 0.0% |
| 1991 Q4 | 5.3 Million USD | 1.92% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -6091.566% |
| BrainsWay Ltd. | 31.78 Million USD | -2249.036% |
| Cerus Corporation | 156.36 Million USD | -377.493% |
| Envoy Medical, Inc. | 316 Thousand USD | -236178.797% |
| electroCore, Inc. | 16.03 Million USD | -4557.773% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -115838.043% |
| IceCure Medical Ltd | 3.22 Million USD | -23022.979% |
| Inogen, Inc. | 315.66 Million USD | -136.533% |
| OrthoPediatrics Corp. | 148.73 Million USD | -402.004% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -30651.277% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -204459.739% |
| MaxCyte, Inc. | 41.28 Million USD | -1708.373% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -38141.412% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -674080.121% |
| PAVmed Inc | 2.45 Million USD | -30350.285% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -3215.605% |
| RxSight, Inc. | 89.07 Million USD | -738.197% |
| Sight Sciences, Inc. | 81.05 Million USD | -821.142% |
| SI-BONE, Inc. | 138.88 Million USD | -437.593% |
| TELA Bio, Inc. | 58.45 Million USD | -1177.336% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -299.021% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -5310.05% |
| Acutus Medical, Inc. | 7.16 Million USD | -10322.125% |
| Talis Biomedical Corporation | 412 Thousand USD | -181123.544% |
| Spectral AI, Inc. | 18.05 Million USD | -4035.141% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -7438.021% |
| CVRx, Inc. | 39.29 Million USD | -1800.092% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -76976.12% |
| Bioventus Inc. | 512.34 Million USD | -45.73% |
| Venus Concept Inc. | 76.35 Million USD | -877.868% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -3933.499% |
| LivaNova PLC | 1.15 Billion USD | 35.274% |
| 908 Devices Inc. | 50.22 Million USD | -1386.474% |
| Alphatec Holdings, Inc. | 482.26 Million USD | -54.821% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -969009.859% |
| NeuroPace, Inc. | 65.42 Million USD | -1041.286% |
| LENSAR, Inc. | 42.16 Million USD | -1670.802% |
| Apyx Medical Corporation | 52.34 Million USD | -1326.276% |
| Cutera, Inc. | 212.36 Million USD | -251.577% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -2138.267% |
| BioSig Technologies, Inc. | 18 Thousand USD | -4147905.556% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -347.997% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -3016.848% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 51.566% |
| Axonics, Inc. | 366.37 Million USD | -103.789% |
| Outset Medical, Inc. | 130.37 Million USD | -472.683% |
| IRIDEX Corporation | 51.86 Million USD | -1339.474% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -448.231% |
| IRadimed Corporation | 65.56 Million USD | -1038.827% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -63389.881% |
| INVO Bioscience, Inc. | 3.02 Million USD | -24618.506% |
| Telesis Bio, Inc. | 27.5 Million USD | -2614.17% |
| Viemed Healthcare, Inc. | 183 Million USD | -307.983% |
| Varex Imaging Corporation | 811 Million USD | 7.936% |
| Quipt Home Medical Corp. | 221.74 Million USD | -236.716% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -987.209% |
| Dynatronics Corporation | 32.53 Million USD | -2194.959% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -8503.837% |
| Semler Scientific, Inc. | 68.18 Million USD | -995.038% |
| InMode Ltd. | 492.04 Million USD | -51.741% |
| Bruker Corporation | 2.96 Billion USD | 74.814% |
| Cytosorbents Corporation | 36.34 Million USD | -1954.068% |
| DexCom, Inc. | 3.62 Billion USD | 79.388% |
| Align Technology, Inc. | 3.86 Billion USD | 80.668% |
| Viveve Medical, Inc. | 6.42 Million USD | -11519.063% |
| ZimVie Inc. | 457.43 Million USD | -63.224% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -286.831% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -674080.121% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 0.144% |
| Profound Medical Corp. | 7.33 Million USD | -10084.68% |
| Insulet Corporation | 1.69 Billion USD | 56.005% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -492.206% |
| iCAD, Inc. | 17.31 Million USD | -4211.358% |
| Nuwellis, Inc. | 8.86 Million USD | -8323.296% |
| Biotricity, Inc. | 12.06 Million USD | -6089.336% |
| iRhythm Technologies, Inc. | 492.68 Million USD | -51.547% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -11932.893% |
| PAVmed Inc. | 2.45 Million USD | -30350.285% |
| BIOLASE, Inc. | 49.16 Million USD | -1418.674% |
| Beyond Air, Inc. | 1.15 Million USD | -64321.139% |
| FONAR Corporation | 102.88 Million USD | -625.711% |
| AxoGen, Inc. | 159.01 Million USD | -369.55% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -172.077% |
| Inari Medical, Inc. | 493.63 Million USD | -51.255% |
| UFP Technologies, Inc. | 400.07 Million USD | -86.627% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -4014098.925% |
| Tenon Medical, Inc. | 2.92 Million USD | -25400.034% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -10860.611% |
| AdaptHealth Corp. | 3.2 Billion USD | 76.669% |
| Sintx Technologies, Inc. | 2.62 Million USD | -28321.812% |
| NanoVibronix, Inc. | 2.28 Million USD | -32604.38% |
| Quanterix Corporation | 122.36 Million USD | -510.16% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -2959.377% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -272.351% |
| TransMedics Group, Inc. | 241.62 Million USD | -209.011% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -5289.353% |
| NeuroMetrix, Inc. | 5.9 Million USD | -12551.876% |
| Hyperfine, Inc. | 11.03 Million USD | -6667.957% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -352.096% |
| Biomerica, Inc. | 5.41 Million USD | -13688.384% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -1376.713% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -321.512% |